Veterinary Medicines

Veprafen Tablet

Not authorised
  • Fenbendazole
  • Praziquantel
Download as PDF

Product identification

Medicine name:
Veprafen Tablet
Veprafen Comprimé
Veprafen Tablette
Active substance:
  • Fenbendazole
  • Praziquantel
Target species:
  • Cat
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Fenbendazole
    500.00
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    50.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC13
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Belgium
Package description:
  • Veprafen 10 10 Blister Tablet
  • Veprafen 1 Blister with 6 Tablets
  • Veprafen 1 Blister with 2 Tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratoria Wolfs
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V176766
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download
German (PDF)
Published on: 22/03/2022
Download